). Le-fluconazole-(-triflucan®, 55 5.2.5.4 L'itraconazole (Sporanox®), p.57

M. Grogl, B. Schuster, W. Ellis, and J. Berman, Successful Topical Treatment of Murine Cutaneous Leishmaniasis with a Combination of Paromomycin (Aminosidine) and Gentamicin, The Journal of Parasitology, vol.85, issue.2, pp.354-359, 1999.
DOI : 10.2307/3285646

E. Handman, Leishmaniasis: Current Status of Vaccine Development, Clinical Microbiology Reviews, vol.14, issue.2, pp.229-272, 2001.
DOI : 10.1128/CMR.14.2.229-243.2001

. Scopoli, Deliciae fauna et flora insubricae, 1786.

R. Killick-kendrick, Phlebotomine vectors of the leishmaniases: a review, Medical and Veterinary Entomology, vol.44, issue.6, pp.1-24, 1990.
DOI : 10.1093/jmedent/24.5.587

K. Aoun and A. Bouratbine, Cutaneous Leishmaniasis in North Africa: a review, Parasite, vol.6, issue.5, p.14, 2014.
DOI : 10.1371/journal.pntd.0001633

URL : https://hal.archives-ouvertes.fr/pasteur-01060927

S. Barron, Hemoflagellates: Cutaneous and Mucocutaneous Leishmaniasis. Barron's Medical Microbiology, 1996.

E. Abonnenc, Les phlébotomes de la région éthiopienne (Diptera: Phlebotomidae) Mémoire de l'ORSTOM, pp.1-289, 1972.

J. Adhami, Anomalies morphologiques des phlébotomes (Diptera: Psychodidae) d'Albanie, SSMTP, vol.33, pp.169-173, 1991.

S. Adler and M. Ber, -The transmission of Leishmania tropica by the bite of P. papatasi. Znd, J. med

L. Lachaud, J. Dedet, P. Marty, F. Faraut, P. Buffet et al., Surveillance of leishmaniases in France, 1999 to 2012, Eurosurveillance, vol.18, issue.29, p.20534, 1999.
DOI : 10.2807/1560-7917.ES2013.18.29.20534

URL : https://hal.archives-ouvertes.fr/hal-00874592

C. Mchugh, P. Melby, and S. Lafon, Leishmaniasis in Texas: Epidemiology and Clinical Aspects of Human Cases, The American Journal of Tropical Medicine and Hygiene, vol.55, issue.5, pp.547-55, 1996.
DOI : 10.4269/ajtmh.1996.55.547

A. Magill, M. Grogl, R. Gasser, . Jr, W. Sun et al., Visceral Infection Caused by Leishmania tropica in Veterans of Operation Desert Storm, New England Journal of Medicine, vol.328, issue.19, pp.1383-1390, 1993.
DOI : 10.1056/NEJM199305133281904

R. Coleman, D. Burkett, J. Putnam, V. Sherwood, J. Caci et al., Impact of phlebotomine sand flies on U.S. Military operations at Tallil Air Base, Iraq: 1. background, military situation, and development of a "Leishmaniasis Control Program", J Med Entomol, vol.43, pp.647-62, 2006.

D. Centers, . Control, and . Prevention, Update: Cutaneous leishmaniasis in U.S. military personnel--Southwest, MMWR Morb Mortal Wkly Rep, vol.53, pp.264-269, 2002.

J. Alvar, C. Cañavate, B. Gutiérrez-solar, M. Jiménez, F. Laguna et al., Leishmania and human immunodeficiency virus coinfection: the first 10 years, Clin Microbiol Rev, vol.10, pp.298-319, 1997.

J. Debet, Médecine tropicale -Les leishmanioses, Ellipses Marketing, 1999.

N. Chargui, N. Haouas, F. Akrout, H. Khorchani, J. Zili et al., Apport de la PCR dans le diagnostique de la leishmaniose cutanée (203 cas), Ann Dermatol Venereol, vol.130, p.53, 2003.

R. Monno, G. Giannelli, C. Rizzo, D. Vito, D. Fumarola et al., Recombinant K39 immunochromatographic test for diagnosis of human leishmaniasis, Future Microbiology, vol.18, issue.2, pp.159-70, 2009.
DOI : 10.1051/parasite/2001084355

J. Kubar and K. Fragaki, Recombinant DNA-derived leishmania proteins: from the laboratory to the field, The Lancet Infectious Diseases, vol.5, issue.2, pp.107-121, 2005.
DOI : 10.1016/S1473-3099(05)70085-2

E. Zijlstra, Y. Nur, P. Desjeux, E. Khalil, A. El-hassan et al., Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan, Tropical Medicine and International Health, vol.5, issue.2, pp.108-121, 2001.
DOI : 10.1016/S0035-9203(97)90518-6

URL : http://onlinelibrary.wiley.com/doi/10.1046/j.1365-3156.2001.00680.x/pdf

R. Kumar, K. Pai, K. Pathak, and S. Sundar, Enzyme-Linked Immunosorbent Assay for Recombinant K39 Antigen in Diagnosis and Prognosis of Indian Visceral Leishmaniasis, Clinical and Vaccine Immunology, vol.8, issue.6, pp.1220-1224, 2001.
DOI : 10.1128/CDLI.8.6.1220-1224.2001

E. Lemos, S. Carvalho, R. Corey, and R. Dietze, Avalia????o do teste r??pido utilizando o ant??geno recombinante K39 no diagn??stico da leishmaniose visceral no Brasil, Revista da Sociedade Brasileira de Medicina Tropical, vol.18, issue.2, pp.36-44, 2003.
DOI : 10.1007/s100960050371

URL : https://doi.org/10.1590/s0037-86822003000700011

J. Hartzell, N. Aronson, P. Weina, R. Howard, A. Yadava et al., Positive rK39 serologic assay results in US servicemen with cutaneous leishmaniasis, Am J Trop Med Hyg, vol.79, pp.843-849, 2008.

D. Singh, K. Pandey, V. Das, S. Das, S. Kumar et al., Novel Noninvasive Method for Diagnosis of Visceral Leishmaniasis by rK39 Testing of Sputum Samples, Journal of Clinical Microbiology, vol.47, issue.8, pp.2684-2689, 2009.
DOI : 10.1128/JCM.00988-09

M. Pr and . Nacir, Les techniques de préparation des coupes pour les microscopies optique et électronique, 2011.

I. Vouldoukis, L. Monjour, D. Frommel, M. Rosenheim, and A. Datry, Colomb-Vallet I, Gentillini M Prélèvement par aspiration à l'aiguille dans le diagnostic de la leishmaniose cutanée, Presse méd, vol.2, pp.76-77, 1983.

H. Bryan, J. E. Schimitt, B. S. Rosenblatt, and . Pritt, Laboratory diagnosis of tropical infections, Infect Dis Clin North Am, vol.26, pp.513-54, 2012.

M. Alam, A. Shamsuzzaman, K. Kuhls, and G. Schönian, PCR diagnosis of visceral leishmaniasis in an endemic region, Mymensingh district, Bangladesh, Tropical Medicine & International Health, vol.94, issue.8, pp.499-503, 2009.
DOI : 10.1016/j.pt.2007.12.006

G. Wortmann, L. Hochberg, H. Houng, C. Sweeney, M. Zapor et al., Rapid identification of Leishmania complexes by a real-time PCR assay, Am J Trop Med Hyg, vol.73, pp.999-1004, 2005.

E. Wall, J. Watson, M. Armstrong, P. Chiodini, and D. Lockwood, Epidemiology of Imported Cutaneous Leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: Use of Polymerase Chain Reaction to Identify the Species, The American Journal of Tropical Medicine and Hygiene, vol.86, issue.1, pp.115-123, 2012.
DOI : 10.4269/ajtmh.2012.10-0558

A. Mansur and B. Au, Sensitivity of leishmanin skin test in patients of acute cutaneous leishmaniasis, Dermatol Online J, vol.12, issue.2, 2006.

D. Ozcan, D. Seçkin, A. Allahverdiyev, P. Weina, H. Aydin et al., Liver transplant recipient with concomitant cutaneous and visceral leishmaniasis, Pediatric Transplantation, vol.9, issue.2, pp.228-260, 2007.
DOI : 10.1097/00001432-200304000-00006

L. Rubiano, M. Miranda, M. Arenas, S. Montero, L. Rodríguez-barraquer et al., Noninferiority of Miltefosine Versus Meglumine Antimoniate for Cutaneous Leishmaniasis in Children, The Journal of Infectious Diseases, vol.205, issue.4, pp.684-92, 2012.
DOI : 10.1093/infdis/jir816

T. Navin, B. Arana, F. Arana, J. Berman, and J. Chajon, Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala, Journal of Infectious Diseases, vol.165, issue.3, pp.528-562, 1992.
DOI : 10.1093/infdis/165.3.528

P. Minodier, F. Faraut-gambarelli, R. Piarroux, C. Gire, J. Garnier et al., Traitement de la leishmaniose visc??rale infantile, Archives de P??diatrie, vol.6, issue.1, pp.59-66, 1999.
DOI : 10.1016/S0929-693X(99)80076-1

S. Sundar, J. Chakravarty, D. Agarwal, M. Rai, and H. Murray, Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India, New England Journal of Medicine, vol.362, issue.6, pp.504-516, 2010.
DOI : 10.1056/NEJMoa0903627

S. Sundar, P. Sinha, and M. Rai, Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial, The Lancet, vol.377, issue.9764, pp.477-86, 2011.
DOI : 10.1016/S0140-6736(10)62050-8

S. Sundar, G. Agrawal, M. Rai, M. Makharia, and H. Murray, Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial Commentary: cost and resistance remain issues, BMJ, vol.323, issue.7310, pp.419-441, 2001.
DOI : 10.1136/bmj.323.7310.419

R. Avasthi, S. Chaudhary, and S. Khanna, Visceral leishmaniasis simulating chronic liver disease: successful treatment with miltefosine, Indian J Med Microbiol, vol.27, pp.85-91, 2009.

K. Ritmeijer, T. Horst, R. Chane, S. Aderie, E. Piening et al., Limited Effectiveness of High-Dose Liposomal Amphotericin B (AmBisome) for Treatment of Visceral Leishmaniasis in an Ethiopian Population With High HIV Prevalence, Clinical Infectious Diseases, vol.53, issue.12, pp.152-158, 2011.
DOI : 10.1093/cid/cir674

R. Prasad, R. Kumar, B. Jaiswal, and U. Singh, Miltefosine: An oral drug for visceral leishmaniasis, The Indian Journal of Pediatrics, vol.22, issue.5, pp.143-147, 2004.
DOI : 10.1128/AAC.36.8.1630

S. Sundar, T. Jha, and C. Thakur, Oral miltefosine for the treatment of Indian visceral leishmaniasis, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.100, pp.26-33, 2006.
DOI : 10.1016/j.trstmh.2006.02.011

M. Rahman, B. Ahmed, M. Faiz, M. Chowdhury, Q. Islam et al., Phase IV Trial of Miltefosine in Adults and Children for Treatment of Visceral Leishmaniasis (Kala-Azar) in Bangladesh, The American Journal of Tropical Medicine and Hygiene, vol.85, issue.1, pp.66-75, 2011.
DOI : 10.4269/ajtmh.2011.10-0661

M. Nacher, B. Carme, S. Marie, D. Couppie, P. Clyti et al., Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana, Annals of Tropical Medicine & Parasitology, vol.50, issue.4, pp.331-337, 2001.
DOI : 10.1093/clind/16.3.417

J. Dogra, Current therapies for treatment of cutaneous leishmaniasis in India, Infection, vol.i, issue.4, pp.189-91, 1992.
DOI : 10.1093/clinids/9.Supplement_1.S57

. Aidsinfo and . Com, Clinical guidelines portal. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: what's new in the guidelines, 2013.

A. Jhingram, B. Chawla, S. Saxena, M. Barrett, and R. Madhubala, Paromomycin: Uptake and resistance in Leishmania donovani, Molecular and Biochemical Parasitology, vol.164, issue.2, pp.111-118, 2009.
DOI : 10.1016/j.molbiopara.2008.12.007

J. Soto and J. Toledo, Oral miltefosine to treat new world cutaneous leishmaniasis, The Lancet Infectious Diseases, vol.7, issue.1, p.7, 2007.
DOI : 10.1016/S1473-3099(06)70665-X

B. Salah, A. , B. Massaoud, N. Guedri, and E. , Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis, New England Journal of Medicine, vol.368, issue.6, pp.524-556, 2013.
DOI : 10.1056/NEJMoa1202657

URL : https://hal.archives-ouvertes.fr/pasteur-00793585

B. Salah, A. Buffet, P. Morizot, G. , B. Massoud et al., WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study, PLoS Neglected Tropical Diseases, vol.13, issue.5, pp.432-432, 2009.
DOI : 10.1371/journal.pntd.0000432.s002

URL : https://hal.archives-ouvertes.fr/pasteur-00859427

J. El-on, R. Livshin, Z. Even-paz, D. Hamburger, and L. Weinrauch, Topical Treatment of Cutaneous Leishmaniasis, Journal of Investigative Dermatology, vol.87, issue.2, pp.284-292, 1986.
DOI : 10.1111/1523-1747.ep12696697

N. Sosa, Z. Capitán, J. Nieto, M. Mieto, J. Calzada et al., Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama, The American Journal of Tropical Medicine and Hygiene, vol.89, issue.3, pp.557-563, 2013.
DOI : 10.4269/ajtmh.12-0736

U. Gonzalez, M. Pinart, M. Rengifo-pardo, A. Macaya, J. Alvar et al., Interventions for American cutaneous and mucocutaneous leishmaniasis, Cochrane Database Syst Rev, vol.793, issue.10, 2009.
DOI : 10.4269/ajtmh.1997.57.309

H. Daneshvar, R. Burchmore, P. Hagan, and R. Phillips, Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major, Parasitology, vol.148, issue.11, pp.1243-1250, 2009.
DOI : 10.1006/expr.2001.4656

H. Daneshvar, M. Molaei, H. Kamiabi, R. Burchmore, P. Hagan et al., Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis, Parasite Immunology, vol.128, issue.11-12, pp.722-730, 2010.
DOI : 10.4049/jimmunol.175.4.2517

H. Daneshvar, P. Hagan, and R. Phillips, Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice, Parasite Immunology, vol.236, issue.11-12, pp.589-596, 2003.
DOI : 10.1146/annurev.immunol.13.1.151

J. Soto, P. Fuya, R. Herrera, and J. Berman, Topical Paromomycin/Methylbenzethonium Chloride Plus Parenteral Meglumine Antimonate as Treatment for American Cutaneous Leishmaniasis: Controlled Study, Clinical Infectious Diseases, vol.26, issue.1, pp.56-58, 1998.
DOI : 10.1086/516267

URL : https://academic.oup.com/cid/article-pdf/26/1/56/1004685/26-1-56.pdf

B. Arana, C. Mendoza, N. Rizzo, and A. Kroeger, Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala., The American Journal of Tropical Medicine and Hygiene, vol.65, issue.5, pp.466-470, 2001.
DOI : 10.4269/ajtmh.2001.65.466

G. Morizot, E. Kendjo, O. Mouri, M. Thellier, and A. Pérignon, Travelers With Cutaneous Leishmaniasis Cured Without Systemic Therapy, Clinical Infectious Diseases, vol.57, issue.3, pp.370-38067, 2013.
DOI : 10.1093/cid/cit269

URL : https://hal.archives-ouvertes.fr/hal-00874622

A. Salah, A. Zaâtour, B. Messaoud, N. Kidar, A. Smith et al., Parasite Load Decrease during Application of a Safe and Easily Applied Antileishmanial Aminoglycoside Cream, PLoS Neglected Tropical Diseases, vol.32, issue.5, p.2749, 2014.
DOI : 10.1371/journal.pntd.0002749.s002

URL : https://hal.archives-ouvertes.fr/hal-01358522

J. Chulay and A. Bryceson, Quantitation of Amastigotes of Leishmania Donovani in Smears of Splenic Aspirates from Patients with Visceral Leishmaniasis *, The American Journal of Tropical Medicine and Hygiene, vol.32, issue.3, pp.475-479, 1983.
DOI : 10.4269/ajtmh.1983.32.475

R. Willard, A. Jeffcoat, P. Benson, and D. Walsh, Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options, Journal of the American Academy of Dermatology, vol.52, issue.6, pp.977-987, 2005.
DOI : 10.1016/j.jaad.2005.01.109

M. El-sayed and A. Anwar, Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study, Journal of the European Academy of Dermatology and Venereology, vol.73, issue.3, pp.335-340, 2009.
DOI : 10.1093/clinids/2.4.520

T. Garnier and S. Croft, Topical treatment for cutaneous leishmaniasis, Curr Opin Investig Drugs, vol.3, pp.538-544, 2002.

E. Braunwald, A. Fauci, and S. Hauser, In : 15 th ed. Harrison's Manual of Medicine, 2001.

A. Masmoudi, A. Dammak, H. Chaaben, N. Maalej, F. Akrout et al., Doxycycline for the treatment of cutaneous leishmaniasis, Dermatol Online J. Aug, vol.1514, issue.8, p.22, 2008.

R. Reithinger, M. Mohsen, M. Wahid, M. Bismullah, R. Quinnell et al., in Kabul, Afghanistan: A Randomized, Controlled Trial, Clinical Infectious Diseases, vol.40, issue.8, pp.1148-55, 2005.
DOI : 10.1086/428736

J. Lemesre, P. Holzmuller, M. Cavaleyra, R. Gonçalves, G. Hottin et al., Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes, Vaccine, vol.23, issue.22, pp.2825-2865, 2005.
DOI : 10.1016/j.vaccine.2004.11.061

M. Kassi, M. Kassi, A. Afghan, R. Rehman, and P. Kasi, Marring Leishmaniasis: The Stigmatization and the Impact of Cutaneous Leishmaniasis in Pakistan and Afghanistan, PLoS Neglected Tropical Diseases, vol.1, issue.10, p.259, 2008.
DOI : 10.1371/journal.pntd.0000259.g002

P. Volf, I. Benkova, J. Myskova, J. Sadlova, L. Campino et al., Increased transmission potential of Leishmania major/Leishmania infantum hybrids, International Journal for Parasitology, vol.37, issue.6, pp.589-93, 2007.
DOI : 10.1016/j.ijpara.2007.02.002

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839924/pdf

N. Aronson, G. Wortmann, S. Johnson, J. Jackson, R. Gasser et al., Safety and Efficacy of Intravenous Sodium Stibogluconate in the Treatment of Leishmaniasis: Recent U.S. Military Experience, Clinical Infectious Diseases, vol.27, issue.6, pp.1457-1464, 1998.
DOI : 10.1086/515027